Prudential Financial’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,099
| Closed | -$216K | – | 2823 |
|
|
2024
Q1 | $216K | Hold |
5,099
| – | – | ﹤0.01% | 2451 |
|
|
2023
Q4 | $216K | Buy |
+5,099
| New | +$216K | ﹤0.01% | 2418 |
|
|
2023
Q1 | – | Sell |
-28,164
| Closed | -$888K | – | 2686 |
|
|
2022
Q4 | $888K | Buy |
28,164
+795
| +3% | +$25.1K | ﹤0.01% | 1768 |
|
|
2022
Q3 | $773K | Buy |
27,369
+10,800
| +65% | +$305K | ﹤0.01% | 1875 |
|
|
2022
Q2 | $438K | Buy |
16,569
+2,090
| +14% | +$55.2K | ﹤0.01% | 2189 |
|
|
2022
Q1 | $507K | Buy |
+14,479
| New | +$507K | ﹤0.01% | 2200 |
|
|
2021
Q4 | – | Sell |
-10,500
| Closed | -$310K | – | 2706 |
|
|
2021
Q3 | $310K | Buy |
+10,500
| New | +$310K | ﹤0.01% | 2304 |
|